Dr. Stan Kutcher, a co-author of a widely disseminated–now discredited ghostwritten report–“Study 329”–who ran for Canadian Parliament, The Coast, a small Canadian newspaper, retracted and then apologized for a story that highlighted about the benefits of the antidepressant, Paxil, for children.
professor of psychiatry who penned his name to aghostwritten report
Project on Government Oversight (POGO) asked NIH Director to take a firm stance against ghostwriting by academics who receive taxpayer funded grants.
“To ghostwrite an entire textbook is a new level of chutzpah,” said Dr. David A. Kessler, former commissioner of the Food and Drug Administration, after reviewing the documents. “I’ve never heard of that before. It takes your breath away.”
Given multiple prior investigations of Dr. Wakefied’s 1998 paper, why did it take the Lancet editors 12 years to discover a lack of proper IRB approval?
The FDA’s expanded marketing approval process for antipsychotics, highly toxic drugs, is unaffected by evidence uncovered by the US Justice Department showing that the studies submitted by drug manufacturers were often flawed, if not fraudulent.
The FDA expanded approval process for toxic drugs is unaffected by evidence uncovered by the US Justice Department showing the studies to be flawed, if not fraudulent.
"JAMA, your integrity is at stake." Chicago Tribune
"The Alliance for Human Research Protection, which is often critical of industry-academic ties, made the requests in a letter it sent Wednesday to the AMA and the journal, also known as JAMA."
FOR IMMEDIATE RELEASE March 27, 2009 AMA REQUESTS JOURNAL OVERSIGHT COMMITTEE REVIEW Statement attributable to: Joseph M. Heyman, M.D. AMA Board Chair "The American Medical Association is owner and publisher of the Journal of the American Medical Association (JAMA) and its specialty Archives journals. While we are…
AHRP has sent a letter of complaint to the American Medical Association and the JAMA Oversight Committee calling for a public apology to Dr. Jonathan Leo by the AMA, a thorough investigation, the immediate suspension of the two editors involved, and a commitment to reviewing, clarifying and publishing JAMA’s editorial policies to protect against future violations of standards for professional conduct
JAMA Editor Ignites Firestorm By Calling Critic a ‘Nobody and a Nothing’_WSJ
The video, "Zyprexa Drug Rep," was posted on YouTube on Dec. 18. When AHRP publicized its (Jan 4) there were something on the order of 38 hits. Since the Infomail was posted on the AHRP website and blog (http://ahrp.blogspot.com the number has reached: 1,429.
